MicuRx mines govt venture fund for Chinese trials of linezolid competitor
This article was originally published in Scrip
Executive Summary
Facing the need to secure new funding for the late-stage clinical development of its lead development project in China, MicuRx Pharmaceuticals has turned to a willing source: a government-supported bioventure fund.